慢性自发性荨麻疹的潜在生物标志物

马 晶晶, 燕 华玲
青海大学附属医院

摘要


慢性荨麻疹是指风团和（或）血管性水肿反复发作≥6周，且每周发作≥2次，其中没有明确的诱发因素的
慢性荨麻疹称之为慢性自发性荨麻疹。在荨麻疹，特别是CSU中，可靠的生物标志物不但可以评估疾病的活动度，
严重程度和持续时间，而且还可以预测对治疗的反应。该文对与CSU可能相关的生物标志物作一综述。

关键词


荨麻疹；慢性；自发性；生物标志物

全文:

PDF


参考


[1]Jian X ,Hou G ,Li L , et al. Identification of pyruvic

and maleic acid as potential markers for disease activity and

prognosis in chronic urticaria. [J]. The Journal of allergy and

clinical immunology, 2024.

[2]A E B ,Jesper E ,H L B , et al. Elevated, FcεRI-dependent MRGPRX2 expression on basophils in chronic

urticaria. [J]. Skin health and disease, 2023, 3 (3): e195-e195.

[3]Metin Z ,Akca M H ,Tur K , et al. Intersecting

pathways: evaluating inflammatory markers and metabolism in

chronic spontaneous urticaria with a multi-marker approach.

[J]. International journal of dermatology, 2024, 63 (5): 604-

610.

[4]A T ,P K ,R A , et al. Chronic urticaria and

coagulation: pathophysiological and clinical aspects. [J].

Allergy, 2014, 69 (6): 683-91.

[5]梁高澎，宋志强.慢性自发性荨麻疹与临床及

实 验 室 生 物 标 志 物 相 关 性 研 究[J].临 床 皮 肤 科 杂 志，

2021，50（05）：317-320.DOI：10.16761/j.cnki.1000-

4963.2021.05.017.

[6]Alicja G ,Aleksandra D ,Edyta M , et al. Chronic

spontaneous urticaria is characterized by lower serum

advanced glycation end-products. [J]. BioMed research

international, 2014, 2014 974154.

[7]T T ,Y S ,S T , et al. Increase of coagulation potential

in chronic spontaneous urticaria. [J]. Allergy, 2011, 66 (3):

428-33.

[8]P K ,F A ,K M C , et al. Potential blood biomarkers

in chronic spontaneous urticaria. [J]. Clinical and experimental

allergy : journal of the British Society for Allergy and Clinical

Immunology, 2017, 47 (1): 19-36.

[9]Masahiko M ,Misato H ,Hiroto Y , et al. IL-6/IL-6

receptor system and its role in physiological and pathological

conditions. [J]. Clinical science (London, England : 1979), 2012,

122 (4): 143-59.

[10]Runqiu L ,Dong L ,Lihua C , et al. The hub

genes and their potential regulatory mechanisms in chronic

spontaneous urticaria revealed by integrated transcriptional

expression analysis. [J]. Experimental dermatology, 2023, 32

(6):

[11]Zhao J ,Ping J ,Wang Y , et al. Vitamin D suppress

the production of vascular endothelial growth factor in mast

cell by inhibiting PI3K/Akt/p38 MAPK/HIF-1α pathway

in chronic spontaneous urticaria [J]. Clinical Immunology,

2020, 215 (prepublish): 108444.

[12]Krzysztof G ,Wojciech M . Serum Levels of Vascular

Endothelial Growth Factor, Platelet Activating Factor and

Eosinophil-Derived Neurotoxin in Chronic Spontaneous

Urticaria—A Pilot Study in Adult Patients [J]. International

Journal of Molecular Sciences, 2022, 23 (17): 9631-9631.

[13]MostmansY ,MaurerM ,RichertB , et al.Chronic

spontaneous urticaria: Evidence of systemic microcirculatory

changes[J].Clinical and Translational Allergy,2024,14(1):e12335-

e12335.

[14]Poddighe D ,Vangelista L .Effects of omalizumab on

basophils: potential biomarkers in asthma and chronic spontaneous

urticaria[J].Cellular Immunology,2020,358104215-104215.

[ 1 5 ] R i k o I T , N i M , I z u m i K , e t a l . T h e

Potential Role of Basophils in Urticaria [J].Frontiers in

Immunology,2022,13883692-883692.

[16]B I ,E G ,E G , et al.Extended diagnostic value of

autologous serum skin test and basophil CD63 expression

assay in chronic urticaria.[J].The British journal of

dermatology,2013,168(3):656-8.

[17]Elena N ,Linda M ,Elham R , et al.Positive

CD63 Basophil Activation Tests Are Common in Children

with Chronic Spontaneous Urticaria and Linked to High

Disease Activity.[J].International archives of allergy and

immunology,2016,171(2):81-88.

[18]Gericke J ,Metz M ,Ohanyan T , et al.Serum

autoreactivity predicts time to response to omalizumab therapy

in chronic spontaneous urticaria[J].The Journal of Allergy and

Clinical Immunology,2017,139(3):1059-1061.e1.

[19]Mandana A Z H ,F H M ,Konstantin K , et al.The

CD63 basophil activation test as a diagnostic tool for assessing

autoimmunity in patients with chronic spontaneous urticaria.

[J].European journal of dermatology : EJD,2019,29(6):614-

618.

[20]Mandana A Z H ,F H M ,Konstantin K , et al.The

CD63 basophil activation test as a diagnostic tool for assessing

autoimmunity in patients with chronic spontaneous urticaria.

[J].European journal of dermatology : EJD,2019,29(6):614-

618.

[21]冯 悦.慢 性 自 发 性 荨 麻 疹 相 关 血 清 学 指 标 的

系 统 评 价 及Meta分 析[D].中 国 医 科 大 学，2019.DOI：

10.27652/d.cnki.gzyku.2019.001036.

[22]Roohi R ,Z. K M ,A. I S , et al.Chronic urticaria

merits serum vitamin D evaluation and supplementation; a

randomized case control study[J].World Allergy Organization

Journal,2015,8(1):15- 15.

[23]Martin K ,Peter E ,Maciej C , et al.Remibrutinib

(LOU064): A selective potent oral BTK inhibitor with

promising clinical safety and pharmacodynamics in a

randomized phase I trial.[J].Clinical and translational

science,2021,14(5):1756-1768.

[24]易红，宋玉杰，江珊，等.补充维生素D_3协同

第二代抗组胺药物治疗慢性自发性荨麻疹的临床疗效观

察和作用机制研究[J].中国麻风皮肤病杂志，2019，35

（03）：144-147.

[25]Deza G ,Ricketti A P ,Giménez-Arnau M A ,

et al.Emerging Biomarkers and Therapeutic Pipelines for

Chronic Spontaneous Urticaria[J].The Journal of Allergy and

Clinical Immunology: In Practice,2018,6(4):1108-1117.

[26]Dehlink E ,Baker H A ,Yen E , et al.Relationships

between levels of serum IgE, cell-bound IgE, and IgE-receptors on peripheral blood cells in a pediatric population.[J].

PLoS ONE,2017,5(8):e12204.

[27]Nicole S ,Riccardo A ,André E , et al.Biomarkers and

clinical characteristics of autoimmune chronic spontaneous urticaria:

Results of the PURIST Study.[J].Allergy,2019,74(12):2427-2436.

[28]Bulfone-Paus S ,Nilsson G ,Draber P , et al.Positive

and Negative Signals in Mast Cell Activation[J].Trends in

Immunology,2017,38(9):657-667.

[29]Kikuchi Y ,Kaplan P A .A role for C5a in

augmenting IgG-dependent histamine release from basophils

in chronic urticaria[J].The Journal of Allergy and Clinical

Immunology,2002,109(1):114-118.

[30]S M ,P K ,T O , et al.Elevated baseline soluble

FcεRI may be linked to early response to omalizumab

treatment in chronic spontaneous urticaria.[J].Journal of

the European Academy of Dermatology and Venereology :

JEADV,2023,38(1):167-174.

[31]Huichun S ,Pavel K ,Jörg S , et al.One in five

patients with chronic spontaneous urticaria has IgE to tissue

transglutaminase 2.[J].Allergy,2023,78(9):2537-2539.

[32]Hong U G ,Ro Y J ,Bae Y , et al.Association of TG2

from mast cells and chronic spontaneous urticaria pathogenesis[J].

Annals of Allergy, Asthma & Immunology,2016,117(3):290-297.

[33]Bae Y ,Kang H S ,Park O J , et al.Serum

transglutaminase 2 activity as a potential biomarker of disease

severity and response to omalizumab in chronic spontaneous

urticaria[J].Allergology International,2020,69(2):304-306.

[34]Zhou H ,Li J ,Gao P , et al.miR-155: A Novel

Target in Allergic Asthma[J].International Journal of

Molecular Sciences,2016,17(10):1773- 1773.

[35]Zhichao M ,Jianwei Q ,Hong Z .MiR-221-3p

as a Potential Biomarker for Patients with Psoriasis and Its

Role in Inflammatory Responses in Keratinocytes.[J].Skin

pharmacology and physiology,2021,34(5):1-7.

[36]M S W ,Trudy M ,C S W , et al.Serum microRNA

signature as a diagnostic and therapeutic marker in patients with

psoriatic arthritis.[J].The Journal of rheumatology,2020,47(12):jrhe

um.190602-jrheum.190602.

[37]Sevil O B K ,Betül D ,Demet C , et al.In chronic

spontaneous urticaria, IgE and C-reactive protein are linked

to distinct microRNAs and interleukin-31.[J].Clinical and

translational allergy,2023,13(8):e12290-e12290.

[38]Jian X ,Hou G ,Li L , et al.Identification of pyruvic

and maleic acid as potential markers for disease activity and

prognosis in chronic urticaria.[J].The Journal of allergy and

clinical immunology,2024.


Refbacks

  • 当前没有refback。